Literature DB >> 29396643

A randomized controlled clinical trial on the effectiveness of three different mouthrinses (chlorhexidine with or without alcohol and C31G), adjunct to periodontal surgery, in early wound healing.

Anastasios M Gkatzonis1, Spyridon I Vassilopoulos2, Ioannis K Karoussis2, Archontia Kaminari3, Phoebus N Madianos2, Ioannis A Vrotsos2.   

Abstract

OBJECTIVES: The use of chlorhexidine (CHX) with or without alcohol has been recommended for a number of clinical applications. On the other hand, there is a plethora of widely subscribed antiseptics, such as agent C31G (alkyl dimethyl glycine/alkyl dimethyl amine oxide), which has not yet been evaluated postsurgically. The effectiveness of three different mouthrinses (CHX with and without alcohol, C31G) in plaque control and early wound healing was compared postoperatively.
MATERIALS AND METHODS: In this, randomized, double-blind, controlled clinical trial 42 patients were allocated to three groups assigned to 2 weeks rinsing after non-regenerative periodontal flap surgery with or without osseous surgery with C31G (group A), alcohol-free CHX 0.12% (group B) or alcohol-based CHX 0.12% (group C). At days 7 and 14, plaque and early wound healing indices were recorded. At day 14, total bacterial counts were estimated utilizing real-time quantitative polymerase chain reaction (qPCR). Statistics included linear and generalized linear mixed models.
RESULTS: At day 7, healing response was not significantly different among groups. At day 14, group A revealed the highest while group C demonstrated the lowest plaque index values (B vs A, odds ratio-OR = 0.18, p = 0.012; C vs A, OR = 0.01, p < 0.001; C vs B, OR = 0.06, p < 0.001). Group C demonstrated the lowest bacterial counts levels at day 14 (38.470 × 106, 48.190 × 106, and 3.020 × 106 for groups A, B, and C, respectively). At day 14, healing was significantly better in group C compared to B (p = 0.007). Group A showed no significant differences compared to other groups.
CONCLUSIONS: (1) The presence of alcohol may increase the effectiveness of CHX in early wound healing, (2) C31G might be an alternative solution prescribed during early postoperative period after non-regenerative periodontal flap surgery. CLINICAL RELEVANCE: The present study found that active agent C31G displayed no significant differences to CHX formulations regarding periodontal wound healing improvement and might be used alternatively after non-regenerative periodontal flap surgery. In addition, an alcohol based 0.12% CHX mouthwash was more effective than an alcohol-free 0.12% CHX and C31G mouthrinse on plaque control in the absence of mechanical oral hygiene.

Entities:  

Keywords:  Alcohol; C31G; Chlorhexidine; Early postsurgical wound healing; Mouthrinses

Mesh:

Substances:

Year:  2018        PMID: 29396643     DOI: 10.1007/s00784-018-2357-6

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  54 in total

1.  Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set.

Authors:  Mangala A Nadkarni; F Elizabeth Martin; Nicholas A Jacques; Neil Hunter
Journal:  Microbiology       Date:  2002-01       Impact factor: 2.777

2.  Efficacy of chlorhexidine mouthrinses with and without alcohol: a clinical study.

Authors:  J L Leyes Borrajo; Varela L Garcia; Castro G Lopez; I Rodriguez-Nuñez; Figueroa M Garcia; Torreira M Gallas
Journal:  J Periodontol       Date:  2002-03       Impact factor: 6.993

3.  Mouthwash use and oral conditions in the risk of oral and pharyngeal cancer.

Authors:  D M Winn; W J Blot; J K McLaughlin; D F Austin; R S Greenberg; S Preston-Martin; J B Schoenberg; J F Fraumeni
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

4.  Comparative evaluation of healing after gingivectomy with electrocautery and laser.

Authors:  Praveen Kumar; Vidya Rattan; Sachin Rai
Journal:  J Oral Biol Craniofac Res       Date:  2015-06-12

5.  In vitro activity of a chlorhexidine-containing mouthwash against subgingival bacteria.

Authors:  W G Wade; M Addy
Journal:  J Periodontol       Date:  1989-09       Impact factor: 6.993

6.  Molecular characterization of subject-specific oral microflora during initial colonization of enamel.

Authors:  Patricia I Diaz; Natalia I Chalmers; Alexander H Rickard; Colin Kong; Craig L Milburn; Robert J Palmer; Paul E Kolenbrander
Journal:  Appl Environ Microbiol       Date:  2006-04       Impact factor: 4.792

7.  6-month use of 0.2% delmopinol hydrochloride in comparison with 0.2% chlorhexidine digluconate and placebo (II). Effect on plaque and salivary microflora.

Authors:  J C Hase; S Edwardsson; J Rundegren; R Attström; E Kelty
Journal:  J Clin Periodontol       Date:  1998-11       Impact factor: 8.728

8.  Effects of low-concentrated chlorhexidine on growth of Streptococcus sobrinus and primary human gingival fibroblasts.

Authors:  S Dogan; H Günay; G Leyhausen; W Geurtsen
Journal:  Clin Oral Investig       Date:  2003-08-22       Impact factor: 3.573

9.  A comparison of a new alcohol-free 0.2% chlorhexidine oral rinse to an established 0.2% chlorhexidine rinse with alcohol for the control of dental plaque accumulation.

Authors:  W Papaioannou; S Vassilopoulos; I Vrotsos; V Margaritis; V Panis
Journal:  Int J Dent Hyg       Date:  2015-10-09       Impact factor: 2.477

10.  Susceptibility of various microorganisms to chlorhexidine.

Authors:  C G Emilson
Journal:  Scand J Dent Res       Date:  1977-05
View more
  2 in total

Review 1.  Antiviral mouthwashes: possible benefit for COVID-19 with evidence-based approach.

Authors:  Mahdieh-Sadat Moosavi; Pouyan Aminishakib; Maryam Ansari
Journal:  J Oral Microbiol       Date:  2020-07-17       Impact factor: 5.474

2.  Effect of photobiomodulation in secondary intention gingival wound healing-a systematic review and meta-analysis.

Authors:  Pooya Ebrahimi; Mahdi Hadilou; Ferdos Naserneysari; Amirmohammad Dolatabadi; Rana Tarzemany; Nafiseh Vahed; Leila Nikniaz; Reza Fekrazad; Leila Gholami
Journal:  BMC Oral Health       Date:  2021-05-13       Impact factor: 2.757

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.